Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia

9 Mar 2006

Abstract excerpt

OBJECTIVES: Chronic lymphocytic leukemia (CLL) is an incurable disease with a highly variable clinical course. IgV(H) mutational status, chromosomal aberrations, CD38 expression and ZAP-70 expression are prognostic markers in CLL, however, they are not exclusively confined to this disease. We recently identified a novel CLL-specific gene (CLL upregulated gene1, CLLU1) that is exclusively upregulated in CLL cells....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium signaling and nucleotide metabolism
Share to Chronic Lymphocytic Leukemia Research
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16529606
DOI: 10.1111/j.0902-4441.2005.t01-1-ejh2530.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemiaPMID 16529606Read ↗

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.Semantic proximity Read ↗

Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia.Semantic proximity Read ↗

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Semantic proximity Read ↗

Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.Semantic proximity Read ↗

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.Semantic proximity Read ↗

LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.Semantic proximity Read ↗

Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.Semantic proximity Read ↗

Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.Semantic proximity Read ↗

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.Semantic proximity Read ↗

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

[Abnormal expression of WWP1 in chronic lymphocytic leukemia and its clinical significance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.